Resseptor Therapeutics

Melbourne, Australia

Resseptor Therapeutics enhances the treatment of the immune system's ability to identify and respond to tissues, malignancies, and pathogens

$1.5M raised

May 2023

Seed

Biotechnology Health Care Therapeutics

Top Investors

IP Group Australia

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Resseptor Therapeutics

How much funding has Resseptor Therapeutics raised?

Resseptor Therapeutics has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in May 2023.

Who are Resseptor Therapeutics's investors?

Resseptor Therapeutics's investors include IP Group Australia.

Where is Resseptor Therapeutics headquartered?

Resseptor Therapeutics is headquartered in Melbourne, Australia.

What does Resseptor Therapeutics do?

Resseptor Therapeutics enhances the treatment of the immune system's ability to identify and respond to tissues, malignancies, and pathogens

What stage is Resseptor Therapeutics at?

Resseptor Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 24, 2023.

MLA

"Resseptor Therapeutics — Funding & Investors." VCBacked, May 24, 2023, https://www.vcbacked.co/company/resseptor-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2023). Resseptor Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/resseptor-therapeutics

Wikipedia (cite web)

{{cite web |title=Resseptor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/resseptor-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 24, 2023.